Funded Health Care Startups in Australia
Among the 50 most recent Australia-based health care rounds shown, Everlab’s $46M (2026-06-16) is the largest disclosed amount, and it sits well above the…
Among the 50 most recent Australia-based health care rounds shown, Everlab’s $46M (2026-06-16) is the largest disclosed amount, and it sits well above the rest of the disclosed figures; the next-largest disclosed amounts cluster around $32M (Splose, 2026-02-08) and $30M (Saluda Medical, 2025-11-15), while most other disclosed rounds are in the low single-digit millions (for example, $2M from Adherium on 2026-06-29 and $3M from CosmoAesthetics on 2025-05-01). Date-wise, there is a tight concentration in mid-2025 to early-2026, with multiple large rounds: Everlab ($46M, 2026-06-16), 4DMEDICAL ($57M, 2026-03-30), and Splose ($32M, 2026-02-08) form a clear run-up to the most recent entries (the latest row is Adherium on 2026-06-29; the earliest is Consultmed on 2022-04-16).
City and stage signals also stand out: Sydney-based companies appear repeatedly (e.g., Everlab, Sonder, Australis Scientific, updoc, and CathRx all in Sydney on different dates), while the list is heavy on “Series Unknown” or blank classifications (31 of 50 rows are labeled Series Unknown and 2 are blank, plus 12 additional rows explicitly “undisclosed” by amount). Outliers are common in size: EMVision Medical’s $290K (2026-05-27) and Peak Medical’s $60K (2024-08-05) are among the smallest disclosed amounts, far below the high-$10M to $50M rounds.
Most recent rounds
50 of 599 more funded startups
This page shows the 50 most recent rounds (back to Apr 2022). The full 59-company history for this listing is available on a paid plan.
Unlock all 59 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in this Australia health care list, and how does it compare to other disclosed amounts?
The largest disclosed amount is 4DMEDICAL’s $57M on 2026-03-30. It is substantially higher than the next-largest disclosed amounts that appear in the table, including Everlab’s $46M (2026-06-16) and a mid-$30M range like Splose’s $32M (2026-02-08).
Where do rounds cluster temporally within the 50 most recent rows?
There’s a dense concentration from mid-2025 into early 2026, including Everlab on 2026-06-16 ($46M), Adherium on 2026-06-29 ($2M), 4DMEDICAL on 2026-03-30 ($57M), and Splose on 2026-02-08 ($32M). The earliest row shown is Consultmed on 2022-04-16 ($1M), so the displayed window spans 2022-04-16 through 2026-06-29.
Which cities appear most often among these companies, and is there a single dominant hub?
Sydney appears repeatedly as the company location across different entries and dates (e.g., Everlab in Sydney on 2026-06-16, Sonder also in Sydney on 2026-06-15, Saluda Medical in Artarmon on 2025-11-15, and updoc on 2024-05-28). Melbourne also shows up frequently (e.g., Adherium on 2026-06-29, 4DMEDICAL on 2026-03-30, and Kismet on 2024-03-04), but Sydney’s presence is especially consistent across years.
How much of the dataset has missing or non-specific stage/amount disclosures?
Stage clarity is limited: 31 of 50 rows are labeled “Series Unknown,” and 2 rows have a blank series field. On the amount side, 12 rows are explicitly “undisclosed,” meaning size comparisons should focus on disclosed-dollar entries like Everlab ($46M) versus EMVision Medical ($290K).
Are there notable small- and large-deal outliers worth prioritizing for diligence?
Yes. Large outliers include 4DMEDICAL ($57M on 2026-03-30) and Everlab ($46M on 2026-06-16), while small disclosed extremes include Peak Medical’s $60K (2024-08-05) and EMVision Medical’s $290K (2026-05-27). These size gaps are much larger than the typical mid-range disclosed entries such as $1M–$10M (e.g., Lenexa Medical $1M on 2023-02-03; Zipline.io $10M on 2022-12-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.